Ashland To Expand Hydroxypropylcellulose Capacity - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ashland To Expand Hydroxypropylcellulose Capacity


Ashland Specialty Ingredients, a commercial unit of Ashland Inc., announced plans to significantly expand production capacity of its Klucel hydroxypropylcellulose (HPC) product line in Hopewell, Virginia. The expansion is expected to begin production in the second half of 2016. Klucel HPC is a tablet binder and coating ingredient used in pharmaceutical applications and dietary supplements worldwide.

Ashland opened a pharmaceutical center of excellence in Hyderabad, India, earlier this year, and is expanding its technical capabilities in Wilmington, Del. and its Polyplasdone crospovidone capacity in Texas City, Texas.

Source: Ashland

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
30%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
7%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics

Click here